These compounds complement rather than replace GLP-1 agonists, potentially allowing lower doses of each for equivalent efficacy
Discussion Hypokalemic Periodic Paralysis was first described at the turn of the century, with the hyperkalemic variant discovered later [3]
The Benefits: A weekly shot to lose weight Helps you feel full faster, longer Improves the way your body responds to sugars Semaglutide/Tirzepatide is not FDA-approved for weight loss, but may be prescribed if a provider deems it appropriate
Medically reviewed by: Dr
Additionally, a recent study looked at health data from older adults with diabetes
Considering that inflammation is a key factor in many diabetic complications, these anti-inflammatory effects of semaglutide could provide additional benefits, particularly in the cardiovascular system [66]